Latest News :
Indiana CE requirements have changed. More...
 
 

 Home | About Us | FAQ | Privacy Statement | Site Map | Contact Us

  
     

  Also visit   
  

 
Home > CE for Doctors > Course Description  
 
TITLE:  Canadian Study of Travatan as Replacement Therapy: (CSTART) Switching to Travatan Can Improve Long-Term Care
ABSTRACT: Glaucoma affects more than 300,000 Canadians and about 67 million people worldwide. The incidence of this disease is growing by 10% yearly. It is the second leading cause of blindness in the world, and the leading cause of blindness among black people. It causes permanent vision loss due to death of retinal ganglion cells and their axons. Treatment is aimed at slowing down disease progression.  Author(s): Thomas Klein, MD
 
Company: Mediconcepts, Inc
Expire Date: 12/01/2006
CE Credits: 1
Price: $20.00
CE Format: PDF
COPE ID: 10619-GL

 

 

  


Problem with a course or test?  Click HERE to request help from the CE provider. 

RATE THE COURSE
Help make EyeCEonline.com more useful! After you complete a course, please take a moment to rate your experience with the online course.

Rate this course: Poor
Fair
Average
Good
Excellent
Course name:
Email address (optional):
 Receive CE updates & news

    
 
 
 

 Home | About Us | FAQ | Privacy Statement | Site Map | Contact Us

  

Copyright © 2006-2009  eyeCEonline.com - All Rights Reserved. Best viewed in 1024x768 resolution.
Any unauthorized reproduction or distribution of the contents of this website is prohibited.